Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 9Warts 2Uterine Cervical Neoplasms 2Condylomata Acuminata 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Dysplasia 1Neoplasms 1High Grade Anal Canal Intraepithelial Neoplasia 1Hematologic Neoplasms 1HIV Infections 1Cancer Survivor 1

Interventions

Cyclophosphamide 3fludarabine phosphate 2Whole-Body Irradiation 2Vincristine 2Vaccines 2Rituximab 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Papillomavirus Vaccines 2Mass Screening 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Etoposide 2Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 2pandemrix 1lactitol 1halofantrine 1focetria 1fludarabine 1efineptakin alfa 1efavirenz 1X-Rays 1VAP-cyclo protocol 1Triage 1Transplantation Conditioning 1Tomography, X-Ray Computed 1Thiotepa 1Therapeutics 1Surveys and Questionnaires 1Standard of Care 1Spirometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × HIV Infections × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT04270773 2024-07-10

9-VPH-MVIH

University Hospital Virgen de las Nieves

Phase 4 Active not recruiting
158 enrolled

HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡